Methohexitalum
Methohexitalum Uses, Dosage, Side Effects, Mechanism of Action, How Long Does it Take to Work? Methohexitalum is a brand name. Its generic name is Methohexital.
Methohexitalum Introduction
Methohexitalum, also known as Brevital, is a fast-acting barbiturate that has sedative-hypnotic and general anaesthetic effects. It is used for general anaesthesia in cosmetic and dental surgery, and to induce deep sedation for short duration medical procedures. Methohexitalum can also be used to prevent epileptic seizures.
Uses for Methohexitalum
Methohexitalum is used to induce general anaesthesia and deep sedation. It is used in cosmetic and dental surgery, and for short duration medical procedures such as bronchoscopy, endoscopy, and transrectal ultrasonography (TRUS). It is also used to prevent epileptic seizures.
Mechanism of Action
Methohexitalum works by increasing the activity of the inhibitory neurotransmitter GABA (gamma-Aminobutyric acid). GABA is a neurotransmitter that reduces the activity of the nerve cells in the brain and spinal cord, and this leads to a decrease in neuronal activity. This results in a calming and sedative effect.
How long does it take to work?
Methohexitalum has a rapid onset of action, usually within 30-60 seconds, and its effects last for 5-15 minutes or more depending on the dose.
Absorption
Methohexitalum is rapidly absorbed after intravenous or intramuscular injection. It is also absorbed after oral administration.
Route of Elimination
Methohexitalum is metabolized in the liver and eliminated primarily by the kidneys.
Dosage
The dose of Methohexitalum for adults is 0.5 mg/kg IV or IM. Inject slowly over 10-15 seconds or slow IV infusion, up to 1mg/kg. The dose for children is 0.5-1 mg/kg IV. Methohexitalum injection should not be given as a bolus injection.
Administration
Methohexitalum can be administered via intravenous injection or infusion, intramuscular injection, and oral tablets.
Side Effects
Common side effects of Methohexitalum include drowsiness, nausea and vomiting, dizziness, headache, restlessness, miosis (constriction of the pupils), and hypotension (low blood pressure). Rare or serious side effects may include respiratory depression, cardiac arrhythmia, and seizures.
Toxicity
High doses of Methohexitalum may lead to respiratory depression, hypotension, coma and death. If Methohexitalum is used in excessive doses, patients may experience central nervous system depression, respiratory depression, and cardiovascular collapse.
Precaution
Methohexitalum should be used with caution in patients with a history of drug abuse, respiratory or cardiovascular diseases, and other relevant medical conditions. It should not be used in patients who have taken other sedative drugs in the past such as benzodiazepines or opioids as they may cause additive effects.
Interaction
Methohexitalum may interact with other drugs, including narcotics, barbiturates, alcohol, antihistamines, and other central nervous system depressants. It should not be used in combination with these drugs as it can lead to additive effects.
Disease Interactions
Methohexitalum should not be used in patients with a history of porphyria or aneurysm or in patients with severe pulmonary disease. It should also not be used in patients with severe hepatic impairment, as the drug is partly metabolized in the liver.
Drug Interactions
Methohexitalum may interact with other drugs, including narcotics, barbiturates, alcohol, antihistamines, and other central nervous system depressants. It should not be used in combination with these drugs as it can lead to additive effects.
Food Interactions
Methohexitalum should not be taken with alcohol or with other drugs that have sedative effects such as barbiturates, narcotics, or antihistamines.
Pregnancy Use
Methohexitalum is not recommended for use in pregnant women as it can cause harm to the unborn baby. Animal studies have shown that Methohexitalum can cause fetal harm and other risks. It should be used only if the potential benefit justifies the potential risk to the fetus.
Lactation Use
Methohexitalum use is not recommended in nursing mothers as it may pass into the breast milk and cause harm to the infant. Nursing mothers should consult their doctor before using Methohexitalum.
Acute Overdose
An acute overdose of Methohexitalum can lead to respiratory depression, hypotension, cardiac arrhythmias, coma, and death. Treatment of overdose typically involves supportive care, such as intravenous fluids and oxygen, and administration of a benzodiazepine or narcotic antagonist.
Contraindication
Methohexitalum is contraindicated in patients with porphyria, severe pulmonary disease, severe hepatic impairment, aneurysm, or an allergy to barbiturates.
Use Direction
Methohexitalum should be used as directed by the doctor or healthcare professional who prescribed it. Follow all instructions carefully and do not use more than prescribed. Do not give Methohexitalum to a child without a doctor’s prescription.
Storage Condition
Methohexitalum should be stored at controlled room temperature, away from light and heat. Do not store in refrigerator or freezer. Keep the medication out of reach of children and pets.
Volume of Distribution
Methohexitalum is widely distributed throughout the body, with an estimated volume of distribution of 0.4 – 0.6 L/kg.
Half Life
The half-life of Methohexitalum is 15-30 minutes.
Clearance
Methohexitalum is mainly metabolized in the liver, with an estimated clearance of 1.08 mL/min/kg.
Here you find in details version of Methohexitalum